Mannatech (MTEX)
Direct seller of Ambrotose-centered nutritional supplements and personal-care products.
Something off on this page? Send us feedback.
Develops and markets proprietary nutritional supplements, skin-care, weight-management, and fitness products through a global network of independent associates and preferred customers. Most revenue is derived from product sales, while access to mainland China relies on cross-border e-commerce rather than licensed direct selling.
Sells proprietary nutritional supplements, skin-care, weight-management, and fitness products, centered on its Ambrotose glyconutrient line, through independent associates and preferred customers in 25 markets. Product sales, associate fees, subscription tools, and training or event fees make up its revenue streams; several Ambrotose and TruHealth products supply a significant share of sales.
Operates mainly through network marketing across the Americas, Asia/Pacific, Europe, the Middle East, and Africa, with South Korea its largest market. Mainland China is served through cross-border e-commerce because the company lacks a Chinese direct-selling license. All products are manufactured by third parties, and arabinogalactan for Ambrotose has no identified alternative supplier. Dietary-supplement and direct-selling rules, including associate health and income claims, shape the operating model.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $6.0M · Total debt $8.5M · Total assets $27.5M · Shareholders' equity −$5.0M
- Revenue
- $26.7M
- Operating income
- $998.0K
- Net income
- $1.0M
HistoryDividendAnnual yield
| Institutions | 7.87% | 151.8K shares | |
|---|---|---|---|
| 16 holders · as of Jun 30, 2026 | |||
| Insiders | 63.04% | 1.22M shares | |
| 9 holders · as of May 21, 2026 | |||
| Other | 29.09% | 561.4K shares | |
| remainder | |||
1.93M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
J. Stanley FredrickInsiderdirector | 18.75% | 361,765 | filed Jan 6, 2026 |
Tyler RamesonInsiderdirector | 15.89% | 306,673 | filed Jan 6, 2026 |
Dayton JuddInsider | 7.01% | 135,274 | filed Jan 27, 2020 |
Lacore TerryInsider | 5.18% | 100,010 | filed Jan 24, 2025 |
Robert TothInsiderdirector | 5.14% | 99,254 | filed Apr 24, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 20, 2026 | Larry A. Jobe | director | +2,803 | $4.12 |
| May 19, 2026 | Kevin Andrew Robbins | director | +7,100 | $4.17 |
| May 19, 2026 | Larry A. Jobe | director | +5,000 | $4.20 |
- Herbalife
Broad wellness and distributor-recruitment rival.
- Nu Skin
Wellness and beauty rival with a global affiliate network.
- USANA Health Sciences
Supplement, personal-care, and distributor-network rival.
- Nature's Sunshine Products
Nutrition and field-sales rival, including Synergy Worldwide.
- LifeVantage
Direct-selling wellness and beauty rival with independent consultants.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Mannatech | $8.03 | −1.47% | $15.7M | — | — | 0.1 | +3.8% |
| Herbalife | $12.07 | +1.26% | $1.24B | 7.7 | 4.5 | 0.2 | +5.4% |
| Nu Skin | $4.79 | +2.24% | $227.2M | — | 5.0 | 0.2 | −17.1% |
| USANA Health Sciences | $14.77 | +1.93% | $267.5M | — | 14.5 | 0.3 | −5.3% |
| Nature's Sunshine Products | $13.16 | +1.08% | $229.0M | 12.9 | 12.2 | 0.5 | +2.0% |
| LifeVantage | $6.25 | +0.55% | $78.5M | 15.5 | 21.6 | 0.4 | −23.1% |
| Median | 12.9 | 12.2 | 0.3 | −5.3% |